Biblio

Found 716 results

2003

Geirsson A, Lynch RJ, Paliwal I, Bothwell ALM, Hammond GL. "Human trophoblast noncoding RNA suppresses CIITA promoter III activity in murine B-lymphocytes." Biochem Biophys Res Commun. 2003;301(3):718-24.

Pober JS, Bothwell ALM, Lorber MI, McNiff JM, Schechner JS, Tellides G. "Immunopathology of human T cell responses to skin, artery and endothelial cell grafts in the human peripheral blood lymphocyte/severe combined immunodeficient mouse." Springer Semin Immunopathol. 2003;25(2):167-80.

Goldberg J, Shrikant P, Mescher MF. "In vivo augmentation of tumor-specific CTL responses by class I/peptide antigen complexes on microspheres (large multivalent immunogen)." J. Immunol.. 2003;170(1):228-35.

Hesslein DGT, Pflugh DL, Chowdhury D, Bothwell ALM, Sen R, Schatz DG. "Pax5 is required for recombination of transcribed, acetylated, 5' IgH V gene segments." Genes Dev. 2003;17(1):37-42.

Zhang Z, Jimi E, Bothwell ALM. "Receptor activator of NF-kappa B ligand stimulates recruitment of SHP-1 to the complex containing TNFR-associated factor 6 that regulates osteoclastogenesis." J Immunol. 2003;171(7):3620-6.

Welte T, Zhang SSM, Wang T, et al. "STAT3 deletion during hematopoiesis causes Crohn's disease-like pathogenesis and lethality: a critical role of STAT3 in innate immunity." Proc Natl Acad Sci U S A. 2003;100(4):1879-84.

Doyle KP, Simon RP, Snyder A, Stenzel-Poore MP. "Working with GFP in the brain." Biotechniques. 2003;34(3):492-4.

2002

Tham ELoon, Shrikant P, Mescher MF. "Activation-induced nonresponsiveness: a Th-dependent regulatory checkpoint in the CTL response." J. Immunol.. 2002;168(3):1190-7.

Egen JG, Kuhns MS, Allison JP. "CTLA-4: new insights into its biological function and use in tumor immunotherapy." Nat. Immunol.. 2002;3(7):611-8.

Kluger MS, Shiao SL, Bothwell ALM, Pober JS. "Cutting Edge: Internalization of transduced E-selectin by cultured human endothelial cells: comparison of dermal microvascular and umbilical vein cells and identification of a phosphoserine-type di-leucine motif." J Immunol. 2002;168(5):2091-5.

Schenten D, Gerlach VL, Guo C, et al. "DNA polymerase kappa deficiency does not affect somatic hypermutation in mice." Eur. J. Immunol.. 2002;32(11):3152-60.

Goodrum FD, Jordan CT, High K, Shenk T. "Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency." Proc. Natl. Acad. Sci. U.S.A.. 2002;99(25):16255-60.

Li JHui, Kluger MS, Madge LA, Zheng L, Bothwell ALM, Pober JS. "Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis." Am J Pathol. 2002;161(4):1485-95.

Pflugh DL, Maher SE, Bothwell ALM. "Ly-6 superfamily members Ly-6A/E, Ly-6C, and Ly-6I recognize two potential ligands expressed by B lymphocytes." J Immunol. 2002;169(9):5130-6.

Zheng L, Ben L-H, Pober JS, Bothwell ALM. "Porcine endothelial cells, unlike human endothelial cells, can be killed by human CTL via Fas ligand and cannot be protected by Bcl-2." J Immunol. 2002;169(12):6850-5.

Wu H-J, Bondada S. "Positive and negative roles of CD72 in B cell function." Immunol. Res.. 2002;25(2):155-66.

2001

Chambers CA, Kuhns MS, Egen JG, Allison JP. "CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy." Annu. Rev. Immunol.. 2001;19:565-94.

Wu HJ, Venkataraman C, Estus S, et al. "Positive signaling through CD72 induces mitogen-activated protein kinase activation and synergizes with B cell receptor signals to induce X-linked immunodeficiency B cell proliferation." J. Immunol.. 2001;167(3):1263-73.

Stumbles PA, Strickland DH, Pimm CL, et al. "Regulation of dendritic cell recruitment into resting and inflamed airway epithelium: use of alternative chemokine receptors as a function of inducing stimulus." J Immunol. 2001;167(1):228-34.

2000

Kuhns MS, Epshteyn V, Sobel RA, Allison JP. "Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells." Proc. Natl. Acad. Sci. U.S.A.. 2000;97(23):12711-6.

Bannert N, Schenten D, Craig S, Sodroski J. "The level of CD4 expression limits infection of primary rhesus monkey macrophages by a T-tropic simian immunodeficiency virus and macrophagetropic human immunodeficiency viruses." J. Virol.. 2000;74(23):10984-93.

1999

Shrikant P, Mescher MF. "Control of syngeneic tumor growth by activation of CD8+ T cells: efficacy is limited by migration away from the site and induction of nonresponsiveness." J. Immunol.. 1999;162(5):2858-66.

Shrikant P, Khoruts A, Mescher MF. "CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism." Immunity. 1999;11(4):483-93.

Chambers CA, Kuhns MS, Allison JP. "Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates primary and secondary peptide-specific CD4(+) T cell responses." Proc. Natl. Acad. Sci. U.S.A.. 1999;96(15):8603-8.

Etemad-Moghadam B, Sun Y, Nicholson EK, Karlsson GB, Schenten D, Sodroski J. "Determinants of neutralization resistance in the envelope glycoproteins of a simian-human immunodeficiency virus passaged in vivo." J. Virol.. 1999;73(10):8873-9.

Pages